Skip to main content
SpringerLink
Log in

Ruxolitinib increases risk of squamous cell cancer

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lin JQ, et al. A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients. Journal of the American Academy of Dermatology : 11 Oct 2021. Available from: URL: http://doi.org/10.1016/j.jaad.2021.10.004

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruxolitinib increases risk of squamous cell cancer. Reactions Weekly 1879, 10 (2021). https://doi.org/10.1007/s40278-021-04494-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-04494-6

Search

Navigation